XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,644,189 | -17.2% | 106,680 | -6.7% | 2.95% | +4.9% |
| Q2 2023 | $4,403,630 | +7.6% | 114,380 | 0.0% | 2.81% | +1.0% |
| Q1 2023 | $4,093,660 | -9.2% | 114,380 | 0.0% | 2.79% | -10.3% |
| Q4 2022 | $4,510,003 | +9.2% | 114,380 | 0.0% | 3.11% | +17.9% |
| Q3 2022 | $4,129,000 | +18.7% | 114,380 | 0.0% | 2.64% | +10.3% |
| Q2 2022 | $3,479,000 | -42.5% | 114,380 | -42.2% | 2.39% | -16.7% |
| Q1 2022 | $6,049,000 | -2.2% | 197,880 | 0.0% | 2.87% | +56.9% |
| Q4 2021 | $6,182,000 | +104.4% | 197,880 | 0.0% | 1.83% | +88.9% |
| Q3 2021 | $3,024,000 | -17.9% | 197,880 | 0.0% | 0.97% | -15.5% |
| Q2 2021 | $3,685,000 | – | 197,880 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |